v.231201
Showing details for project SYSMHC00024
| SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
| SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
| SYSMHC00024_HLA_A0101 |
10 |
Human |
|
|
HLA-A01:01 |
| SYSMHC00024_HLA_A0201 |
4 |
Human |
|
|
HLA-A02:01 |
| SYSMHC00024_HLA_A0203 |
4 |
Human |
|
|
HLA-A02:03 |
| SYSMHC00024_HLA_A0204 |
6 |
Human |
|
|
HLA-A02:04 |
| SYSMHC00024_HLA_A0207 |
4 |
Human |
|
|
HLA-A02:07 |
| SYSMHC00024_HLA_A0301 |
4 |
Human |
|
|
HLA-A03:01 |
| SYSMHC00024_HLA_A2402 |
4 |
Human |
|
|
HLA-A24:02 |
| SYSMHC00024_HLA_A2902 |
2 |
Human |
|
|
HLA-A29:02 |
| SYSMHC00024_HLA_A3101 |
4 |
Human |
|
|
HLA-A31:01 |
| SYSMHC00024_HLA_A6802 |
8 |
Human |
|
|
HLA-A68:02 |
| SYSMHC00024_HLA_B3501 |
1 |
Human |
|
|
HLA-B35:01 |
| SYSMHC00024_HLA_B4402 |
8 |
Human |
|
|
HLA-B44:02 |
| SYSMHC00024_HLA_B4403 |
7 |
Human |
|
|
HLA-B44:03 |
| SYSMHC00024_HLA_B5101 |
5 |
Human |
|
|
HLA-B51:01 |
| SYSMHC00024_HLA_B5401 |
9 |
Human |
|
|
HLA-B54:01 |
| SYSMHC00024_HLA_B5701 |
3 |
Human |
|
|
HLA-B57:01 |
Detailed view of sample SYSMHC00024_HLA_A3101
| ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue Type |
Cell Type |
Culture Conditions |
Disease State |
Comments |
MHCClass |
MHCAllele |
PubMed ID |
Peptide |
Isolation Method |
Antibody |
Mass Spectrometer |
LC System |
iRT Peptides |
Acquisition Mode |
Fragmentation Method |
Gradient |
Gradient Length |
Flow Rate |
Replicate Number |
| ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue_Type |
Cell_Type |
Culture_Conditions |
Disease_State |
Comments |
MHCClass |
MHCAllele |
PubMed_ID |
Peptide |
Isolation_Method |
Antibody |
Mass_Spectrometer |
LC_System |
iRT_Peptides |
Acquisition_Mode |
Fragmentation_Method |
Gradient |
Gradient_Length |
Flow_Rate |
Replicate_Number |
| SYSMHC00024 |
SYSMHC00024_HLA_A3101 |
C20150427_JGA_3uLof6uL_1e8ceq_HLA_A31_IP_rep1.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
|
|
|
class I |
HLA-A31:01 |
28228285 |
native |
Immunoaffinity |
W6/32 |
Q-Exactive |
Proxeon Easy NanoLC 1000 |
no |
DDA |
HCD |
|
|
|
1 |
| SYSMHC00024 |
SYSMHC00024_HLA_A3101 |
C20150427_JGA_3uLof6uL_1e8ceq_HLA_A31_IP_rep2.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
|
|
|
class I |
HLA-A31:01 |
28228285 |
native |
Immunoaffinity |
W6/32 |
Q-Exactive |
Proxeon Easy NanoLC 1000 |
no |
DDA |
HCD |
|
|
|
2 |
| SYSMHC00024 |
SYSMHC00024_HLA_A3101 |
M20150626_JGA_HLA_A31_biorep1_5e7ceq_reinject_AcOHmobilephase.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
|
|
|
class I |
HLA-A31:01 |
28228285 |
native |
Immunoaffinity |
W6/32 |
Q-Exactive |
Proxeon Easy NanoLC 1000 |
no |
DDA |
HCD |
|
|
|
3 |
| SYSMHC00024 |
SYSMHC00024_HLA_A3101 |
M20150626_JGA_HLA_A31_biorep2_5e7ceq_reinject_AcOHmobilephase.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
|
|
|
class I |
HLA-A31:01 |
28228285 |
native |
Immunoaffinity |
W6/32 |
Q-Exactive |
Proxeon Easy NanoLC 1000 |
no |
DDA |
HCD |
|
|
|
4 |